Healthpeak Properties (DOC) Financials

Healthpeak Properties (NYSE:DOC) has shown a mixed but generally improving operating picture, with strong cash generation in Q1 2026, but still carrying a leveraged balance sheet and some earnings volatility. Over the last several years, revenue has held relatively steady in the $500 million to $665 million quarterly range, while net income has swung significantly quarter to quarter due to non-operating items, depreciation, restructuring charges, and other special charges.

What stands out most: DOC continues to produce solid operating cash flow, but it also depends heavily on financing activity and debt management. In Q1 2026, operating cash flow was $260.9 million and net income attributable to common shareholders was $193.5 million, a strong rebound from a loss in Q3 2025 and an improvement from prior-year levels in some periods.

• Q1 2026 operating cash flow remained strong at $260.9 million, supporting dividend coverage and internal funding capacity.
• Net income attributable to common shareholders improved to $193.5 million in Q1 2026, up sharply from $113.8 million in Q4 2025 and a loss in Q3 2025.
• Total revenue in Q1 2026 was $665.7 million, above Q4 2025 and consistent with the company’s recent revenue range.
• Cash and equivalents rose to $1.17 billion in Q1 2026 from $119.8 million at year-end 2024, giving the company a much stronger liquidity position.
• The company ended Q1 2026 with $9.03 billion in total equity and noncontrolling interests, up from $9.06 billion at year-end 2024, showing a relatively stable equity base despite volatility.
• Revenue has been fairly stable over time, generally staying in the mid-$600 million range in recent quarters, which suggests a resilient underlying business model.
• Depreciation remains large, at $289.7 million in Q1 2026, which is typical for a real estate-heavy business but keeps accounting earnings less reflective of cash generation.
• DOC’s share count has been broadly stable, with diluted shares around 695 million in Q1 2026, limiting dilution risk for now.
• Debt remains significant, with $10.42 billion of total debt in Q1 2026, including $1.75 billion of short-term debt and $8.67 billion of long-term debt.
• Net interest income stayed negative at -$73.1 million in Q1 2026, meaning interest costs continue to weigh on profitability.

Trend analysis over the last four years: DOC’s quarterly net income has been highly uneven, ranging from strong positives in 2022 and early 2024 to losses in parts of 2025. For example, Q3 2025 showed a net loss of $109.8 million, while Q1 2025 produced $50.1 million in net income and Q1 2026 jumped to $199.7 million. That kind of volatility suggests earnings are still influenced by one-time items and portfolio-level adjustments rather than smooth, predictable growth.

Balance sheet trends are more concerning than the income statement trend. Total assets have fluctuated around the high teens to low $20 billions, but debt has stayed elevated throughout the period. DOC’s liability load improved somewhat from 2024 into 2026, but leverage is still meaningful. The company has also relied on debt issuance and repayment activity in the cash flow statement, which is common for real estate firms but still increases sensitivity to rates and refinancing conditions.

Bottom line: Healthpeak Properties looks like a cash-generating REIT with a decent liquidity buffer and recent earnings recovery, but investors should keep an eye on leverage, interest expense, and the durability of earnings. The stock’s long-term appeal will likely depend on whether management can keep cash flow strong while reducing balance sheet pressure and limiting earnings volatility.